In Asia, the insurance regulatory regimes vary significantly across the markets, often making it difficult for insurers to keep track of how the regulations change across the region. This research report provides a summary of Asian life insurance regulatory regimes. It covers an overview of the current regulations applicable to life insurers in 14 Asian markets.
The literature shows that a disease management programme is not a guarantee of cost savings, but in addition to community health improvements and improved clinical outcomes, desired cost savings can be realised if the programme is designed correctly.
This report compares and contrasts the various different approaches taken to embedded value reporting across Asian markets and insurers.
Dermot is Milliman’s President and Chief Executive Officer. He spearheads the firm’s growing global presence with a commitment to delivering high-quality solutions for clients and through commitment to the firm’s core...